Topics

Gliomas | Diagnosis | Differentiation

Home > Publications > Topics > Gliomas > Diagnosis > Differentiation

Moltoni G, Romano A, Capriotti G, Campagna G, Ascolese AM, Romano A, Dellepiane F, Minniti G, Signore A, Bozzao A.
ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes.
Radiol Med. 2024 Aug 8. doi: 10.1007/s11547-024-01862-3. PMID: 39117936. Observational study. ˍ

Wu X, Zhang M, Jiang Q, Li M, Wu Y.
Diagnostic accuracy of magnetic resonance diffusion tensor imaging in distinguishing pseudoprogression from glioma recurrence: a systematic review and meta-analysis.
Expert Rev Anticancer Ther. 2024 Oct 14;24(11):1177-1185. doi: 10.1080/14737140.2024.2415404. PMID: 39400036. Review; Meta-analysis˰ ˍ

Amide proton transfer-weighted (APTw) MRI

Karimian-Jazi K, Enbergs N, Golubtsov E, Schregel K, Ungermann J, Fels-Palesandro H, Schwarz D, Sturm V, Kernbach JM, Batra D, Ippen FM, Pflüger I, von Knebel Doeberitz N, Heiland S, Bunse L, Platten M, Winkler F, Wick W, Paech D, Bendszus M, Breckwoldt MO.
Differentiating Glioma Recurrence and Pseudoprogression by APTw CEST MRI.
Invest Radiol. 2024 Dec 9. doi: 10.1097/RLI.0000000000001145. PMID: 39644107. Interventional study˰ ˍ

Combination of MRI characteristics with IDH mutation status

Ganesan G, Rangasami R, Chandrasekharan A, Marreddy S, Ramachandran R.
Role of Advanced Magnetic Resonance Imaging in Differentiating among Glioma Subtypes and Predicting Tumor-Proliferative Behavior.
Asian J Neurosurg. 2024 Oct 15;20(1):34-42. doi: 10.1055/s-0044-1790508. PMID: 40041591. Observational study. ˍ